ClinicalTrials.gg
Enrolling by invitationNCT06910800PACMANUpdated Apr 11, 2025

Indwelling Pleural Catheters: a Self-management Intervention

An observational study in Indwelling Pleural Catheter, sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-11.

Sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
116
Ages
18 Years and older
Sex
All
01

Study summary

A pleural effusion is a build-up of fluid around the lung. In the UK, about quarter of a million people develop a pleural effusion each year. They are usually caused by advanced cancer or heart, kidney, or liver failure. People with a pleural effusion feel breathless and can't do the things they want to. Draining the fluid improves breathlessness and quality of life. This can be done by inserting a semi-permanent tube called an indwelling pleural catheter (IPC). This is drained at home about three times a week.

Drainage is usually done by a community nurse. However, it can be done by the patient or family/unpaid carers - this is called self-management. Self-management gives the patient the freedom to drain their IPC when they need to, without having to wait at home until a nurse is available. It reduces the burden on community nursing services. Despite these benefits, not all patients get the opportunity to self-manage.

The aim of this study is to help more patients self-manage if they want to. We will achieve this through three stages:

Stage 1: We will talk to patients with IPCs as well as their families/carers to find out their views on self-management and what stops people who could self-manage from doing so. We know that patients with an IPC can be frail. Often their families/carers are already doing a lot to support them. We will ask what might help them to self-manage if they would like to.

Stage 2: We will talk to healthcare professionals (HCPs) looking after patients with IPCs to understand what they think about self-management. This will include community nurses and the hospital teams who put IPCs in.

Stage 3: Along with our patients, their families/unpaid carers and HCPs, we will hold workshops to design an intervention that will help people to self-manage IPCs. We don't know what this intervention will look like yet. From talking to patients and families who already self-manage, we have found they like to learn from a demonstration on their own IPC followed by supervised self-management until they feel confident. Therefore, our intervention may include training sessions for HCPs on how to teach self-management.

This study grew from conversations with our patients. People with an IPC, family members and community nurses helped design the study. Our patient and public involvement (PPI) group will help design study materials and guide the study.

Read the detailed description

Research question:

How can patients with an indwelling pleural catheter (IPC) and their family/unpaid carers be supported to self-manage?

Background:

Pleural effusion is the accumulation of fluid in the space between the lung and chest wall. It is a common complication of malignancy and affects approximately 200-250,000 people annually in the UK. People with such an effusion experience disabling breathlessness; this is treated by draining the fluid using IPCs (semi-permanent chest drains). These are usually managed at home by community nurses, but this can be done by the patient, family member or carer. Supported self-management is part of the NHS long term plan and British Thoracic Society guidelines state that patients should be supported to self-manage their IPC to promote independence. However, there is no evidence to support these recommendations, nor guidance on how self-management should be facilitated. There is thus an evidence gap at the heart of current recommendations.

Objectives:

O1. Identify support needs of patients with IPCs and their family/unpaid carers and how these impact on the acceptability and feasibility of self-management.

O2. Identify barriers and motivators to IPC self-management among patients and family/unpaid carers.

O3. Understand healthcare professional (HCP) attitudes toward, and practices related to, IPC self-management.

O4. Co-design and develop an evidence-based intervention to facilitate IPC self-management.

Methods:

An applied qualitative study and co-design project comprising three stages mapped to the four objectives.

S1: semi-structured interviews with patients with an IPC and their family/unpaid carers regarding self-management and support needs.

S2: focus groups and interviews with community nurses and IPC service staff regarding self-management.

S3: co-design and development of a self-management intervention.

Interviews will be audio- or audiovisual-recorded (with permission), transcribed, and analysed using thematic analysis. Codes will be assigned to text to categorise meanings. Given the lack of prior research, the coding schema will be developed inductively from early transcripts (with reference to literature from other fields), refined and applied to subsequent transcripts. Codes will be categorised, themes identified, and the results developed into a narrative. The COM-B system will be the model of reference for the development of the self-management intervention. This is comprised of a behaviour change wheel linked to intervention functions and policy categories.

Inclusion criteria Stage 1 - patients and family/unpaid carers

  • Adult (>18 years) who has (or has had) an IPC OR
  • Adult family member or unpaid carer of a patient who has (or has had) an IPC
  • Patients may currently be self-managing or receiving CN care. Stage 2 - healthcare professionals
  • Community nurse: experience of caring for a patient with an IPC within the last 12 months and signed-off as competent in IPC management
  • IPC-insertion site staff: any HCP involved in discussion with patients about post-insertion IPC care Stage 3 - co-design groups
  • as above

Exclusion criteria Stage 1 - patients

  • Patient with a life expectancy of less than 6 weeks
  • Patient or family/unpaid carer who lacks capacity to offer informed consent (as judged by a suitably qualified HCP in accordance with Good Clinical Practice guidelines) Stage 2 - Health care professionals
  • None Stage 3 - co-design groups
  • As above

Anticipated Impact and Dissemination

The principal output will be a prototype self-management intervention for patients with an IPC and their family/unpaid carers that will:

  • Empower patients, increase perceived symptom control, and reduce time spent 'waiting in' for nursing visits;
  • Relieve pressure on community nursing services and reduce healthcare costs;
  • Support the NHS long term plan by enabling supported self-management;
  • Facilitate more frequent drainage which may prevent re-accumulation of pleural fluid.
02

Conditions studied

  • Indwelling Pleural Catheter

Browse trials for

Keywords

  • Indwelling pleural catheter
  • Tunnelled pleural catheter
  • IPC
  • Pleural effusion
  • Self-management
  • Support needs
03

In context

Pleural Effusion

241 studies on the registry are indexed under Pleural Effusion; 50 are open to participants now.

This study's planned enrollment of 116 is below the median of 140 across 93 observational studies indexed under Pleural Effusion.

Browse Pleural Effusion studies →

Lead sponsor

Norfolk and Norwich University Hospitals NHS Foundation Trust is the lead sponsor of 30 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

UK patients who have (or have had) an indwelling pleural catheter, and their family/unpaid carers. UK healthcare professionals who work with patients who have IPCs, including community nurses and IPC-insertion centre staff.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Stage 1 - Patients and family/unpaid carers

    • Adult (>18 years) who has (or has had) an IPC OR
    • Adult family member or unpaid carer of a patient who has (or has had) an IPC
    • Patients may currently be self-managing or receiving CN care.

Stage 2 - Healthcare professionals

  • Community nurse: experience of caring for a patient with an IPC within the last 12 months and signed-off as competent in IPC management
  • IPC-insertion site staff: any HCP involved in discussion with patients about post-insertion IPC care

Stage 3 - Co-design groups

o as above

Exclusion criteria

Exclusion Criteria:

  • Stage 1 - Patients

    • Patient with a of less than 6 weeks
    • Patient or family/unpaid carer who lacks capacity to offer (as judged by a suitably qualified HCP in accordance with Good Clinical Practice guidelines)

Stage 2 - Health care professionals o None

Stage 3 - Co-design groups

o As above

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
116 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients

    Patients who have (or have had) an IPC.

  • Family members and unpaid carers

    Family members and unpaid carers of patients who have (or have had) an IPC.

  • Healthcare professionals

    Community nurses involved in IPC care and healthcare professionals involved in IPC insertion.

06

What researchers measure

Primary outcomes

  1. Capturing Health Care Professionals attitudes toward and beliefs about self-management

    Data will be collected via focus groups and interviews. The different data collection designs reflect the nature of how the two groups of HCPs work and working patterns. The topic guide for the two activities will thus be largely the same and given the common subject matter it will be possible to analyse the qualitative data from these two approaches together. There will be some additional, group-specific, questions reflecting the different roles these two HCP groups play in the patient care pathway. The four objectives to achieve this are: 1. to identify support needs in relation to IPC and how unfulfilled needs impact ability to self-manage. 2. to identify barriers and motivators to IPC self-management among patients and family/unpaid carers. 3. to understand HCP attitudes toward, and practices related to, IPC-self-management. 4. to work with stakeholders to co-develop an intervention to facilitate IPC self-management.

    Time frame: Periprocedural

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The study will be publicised to stakeholders. Online resources may be hosted and promoted via the MyPleuralEffusionJourney and UKPS websites. Further opportunities for promotion will be explored including direct contact with services previously identified as using self-management infrequently.

Supporting information: Clinical study report

Time frame: Throughout study duration.

Access criteria: Stakeholders including - but not limited to: Regional integrated care boards, and participating NHS trusts / study recruitment sites. Influential third sector organisations such as Mesothelioma UK IPC manufacturers Relevant charities such as Breast Cancer UK and the Roy Castle lung cancer foundation. Via the FutureNHS platform. Members of the BTS Pleural Guideline Development group

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Apr 2026, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2025
First posted
Apr 4, 2025
StartActual
Nov 12, 2024
Primary completionEst.
Apr 30, 2026
CompletionEst.
Apr 30, 2026
Last update
Apr 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06910800
Lead sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Collaborators
University of East Anglia
Responsible party
Sponsor
First posted
Apr 4, 2025
Start date
Nov 12, 2024
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Apr 11, 2025

Study contacts

Adam M Dr Peel
principal investigator · Norfolk and Norwich University Hospitals NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion